RSS

breathalysers

Diagnostics company, Owlstone Medical, has raised $15 million to drive the global commercialisation of its Breath Biopsy device. more

News

A medical breathalyser device is being used by a pharmaceuticals firm to discover treatments for cancer, as well as gastrointestinal, autoimmune, and respiratory conditions. more

News